| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.054 | 0.3 |